Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Get in touch


Health is critical to our wellbeing as individuals, plays a key role in societal and economic advances, and presents many opportunities for environmental impact. Innovations in health & care allow us to alleviate suffering, increase quality of life and life expectancy, and manage the needs of a changing and ageing population.


The “Health sector” which delivers these innovations is diverse and covers a wide range of business activities. KTN covers the whole sector by focusing on the broad sub sectors of Medicines, Medical Technology and Digital Health. The logic behind this focus is that each of the sub-sectors is a significant sector in its own right and has distinct characteristics. The Health team at KTN has considerable experience of working in these sub-sectors and of driving cross-sector working to facilitate positive change.

AI in Health

The application of Artificial Intelligence and machine learning to the field of health represents a major opportunity for the UK. AI is a powerful tool that can be applied across industry sectors to solve specific challenges. The application of these tools in Health requires a mutual understanding between the AI and Health communities.

Digital Health & Care

The digital health and care sub-sector is characterised by a large number of small companies developing technology across the health spectrum.



The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME “biotech” companies.


Medicines Discovery Landscape

Connecting the UK’s growing Medicines Discovery community with industrial collaborators, research-based expertise, investment opportunities and funders.

Medicines Manufacturing Landscape

Connecting the UK’s growing Medicines Manufacturing community with industrial collaborators, research-based expertise, investment opportunities and funders.


Medical technologies touch all of our lives – from pregnancy testing and ultrasound scans before birth; through wound care products for childhood injuries; to diagnostic imaging systems and therapeutic implants for disease in adults.


The Microbiome Innovation Network (formerly SIG) aims to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia.


From bioelectronic medicine that treat chronic diseases, to brain-computer interfaces that help stroke rehabilitation, neurotechnology will play an increasingly important role in meeting some of the challenges of an ageing society.

Precision Medicines Landscape

Connecting the UK’s growing Precision Medicines community with industrial collaborators, research-based expertise, investment opportunities and funders.

Funding Opportunities

Care Home Data Platform Innovation Foundation Challenge

This Challenge will invite companies to assess if currently collected data on residents by care homes, can – alone or when combined with health and social care records – provide a holistic digital picture of a resident’s health, wellbeing and care needs.

Opens: 16/12/2020 Closes: 05/02/2021

Explore Further

SBRI : Improving Multimorbidity Acute Care Using Data Analytics, phase 1

Organisations can apply for a share of £160,000 inclusive of VAT to develop a data-driven solution to improve the care and outcomes for patients with multimorbidity admitted to A&E, working with Health Innovation South East Scotland.

Opens: 04/01/2021 Closes: 03/03/2021

Explore Further

KTN Innovation Exchange challenge - technologies to be adapted in public spaces in a post-Covid world

KTN is working with the Department for International Trade to help the Indian government open up the Indian markets to the capability of using technology for safer public space operation.

Opens: 18/12/2020 Closes: 12/02/2021

Explore Further



Neurotechnology Webinar Series: Developing the UK’s Neurotechnology Capabilities

10.00 - 12.00 | Online

Watch Now


Emerging & Novel Sensing Technologies for Precision Medicine & Digital Health

10.00 - 12.00 | Online

Watch Now


What is 5G and its role in the health sector and panel session

10.30 - 11.30 | Online

Watch Now



Vaccine Innovation in the UK: SMEs and National Capabilities

An article summarising the UK Government’s investment in vaccine innovation has been published in European Pharmaceutical Review, by KTN’s Dr Gabriela Juárez Martínez and Dr Marcel Kuiper.

Read more


Knowledge Transfer Partnership helps power production of the new Covid-19 vaccine

A Knowledge Transfer Partnership (KTP) between the University of Exeter and Smart Manufacturing Ltd is playing a direct and key role in the production process of the new COVID-19 vaccine.

Read more